| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |